Search or ask a question

Is heterdimeraization between AT1 receptors and B2R occured in wild type mice?

5-HT5A receptor

Angiotensin-converting enzyme

Angiotensin receptor

Interleukin-21 receptor

Protein maturation

Best insight from top research papers

Heterodimerization between AT1 receptors and B2R occurs in wild type mice .

Answers from top 5 papers

PDF

Open Access

More filters

Papers (5)	Insight
Journal Article•DOI Differential expression of angiotensin receptor 1A and 1B in mouse. J. M. Burson, G. Aguilera, K. W. Gross, Curt D. Sigmund - Show less +3 more 01 Aug 1994-American Journal of Physiology-endocrinology and Metabolism 231 Citations	The provided paper does not mention anything about heterodimerization between AT1 receptors and B2R in wild type mice.
Journal Article•DOI Increased AT1 receptor expression and mRNA in kidney glomeruli of AT2 receptor gene-disrupted mice Juan M. Saavedra, Walter Häuser, Gladys M. Ciuffo, Giorgia Egidy, Kwang Lae Hoe, Olaf Jöhren, Takaaki Sembonmatsu, Tadashi Inagami, Ines Armando - Show less +8 more 01 Jan 2001-American Journal of Physiology-renal Physiology 33 Citations	The provided paper does not mention anything about heterodimerization between AT1 receptors and B2R in wild type mice.
Journal Article•DOI Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. Said AbdAlla, Ahmed Abdel-Baset, Heinz Lother, Adel el Massiery, Ursula Quitterer - Show less +4 more 01 Jan 2005-Journal of Molecular Neuroscience 98 Citations	The paper does not mention whether heterodimerization between AT1 receptors and B2R occurs in wild type mice.
Open access•Journal Article•DOI Protective role of AT2 and B1 receptors in kinin B2-receptor-knockout mice with myocardial infarction Jiang Xu, Oscar A. Carretero, Liping Zhu, Edward G. Shesely, Nour Eddine Rhaleb, Xiangguo Dai, Luchen Wang, James J. Yang, Xiao Ping Yang - Show less +8 more 01 Jan 2013-Clinical Science 14 Citations	The provided paper does not mention anything about heterodimerization between AT1 receptors and B2R in wild type mice.
Open access•Journal Article•DOI Establishment of an in vivo model facilitates B2 receptor protein maturation and heterodimerization Joshua Abd Alla, Armin Pohl, Kristin Reeck, Thomas Streichert, Ursula Quitterer - Show less +4 more 07 Apr 2010-Integrative Biology 16 Citations	The paper does not mention whether heterodimerization between AT1 receptors and B2R occurs in wild type mice.

My columns

Related Questions

Is there evidence of cannabinoid receptor heterodimers?4 answersThere is evidence of cannabinoid receptor heterodimers. The cannabinoid CB1 receptor (CB1) has been shown to form heterodimers with the dopamine D2 receptor (D2R). Additionally, the chemokine receptor CXCR4 and the cannabinoid receptor CB2R have been found to form heterodimers in non-Hodgkin lymphoma (NHL) and solid tumors. The formation of CB1-D2L heterodimers has been observed in a neuronal cell model. Furthermore, bivalent CB1 and orexin OX1 ligands have been designed and tested for activity against CB1 and OX1 receptors, suggesting possible interaction with CB1-OX1 dimers. These findings provide evidence for the existence of cannabinoid receptor heterodimers.

Which receptors are affected by caffeine ?4 answersCaffeine affects adenosine receptors (ADORs) and ryanodine receptors (RYRs) in the brain. It acts as an antagonist of ADORs, particularly ADORA1, ADORA2B, and ADORA3, and reduces the inhibitory effect of inflammation on ADORA1 in the mediobasal hypothalamus (MBH). Caffeine also decreases the stimulatory effect of endotoxin treatment on ADORA2B in the MBH and choroid plexus (ChP). In terms of RYRs, the expression of these receptors is less sensitive to the effects of inflammation and caffeine. Additionally, caffeine has an impact on NMDA receptor (NMDAR) activity in the hippocampus, likely mediated by blockade of inhibitory A1Rs and involvement of A2ARs. Caffeine also increases the metabolic competence of synapses, potentially through increased glycolytic rate and astrocyte-synapse lactate shuttling. Furthermore, caffeine's ergogenic effects are mediated by antagonism of A2ARs in forebrain neurons.

How are orexin neurons heterogenous?5 answersOrexin neurons are heterogeneous in several ways. Firstly, they display heterogeneous time courses of miniature excitatory postsynaptic currents (mEPSCs), with some neurons showing fast mEPSCs and others showing slow mEPSCs. Secondly, orexin neurons have heterogeneous projections to different regions of the brain, including the paraventricular spinal cord. Thirdly, there is functional heterogeneity among orexin-containing neurons in the hypothalamus, with different neurons being involved in the regulation of feeding behavior, sleep/wake cycle, and immune functions. Lastly, orexin neurons receive heterogeneous inputs from different types of neurons in the basal forebrain, including glutamatergic and GABAergic neurons, but not cholinergic neurons. These findings suggest that orexin neurons have diverse properties and functions, contributing to their role in regulating various physiological processes.

Can receptor heterogeneity be used to predict drug response or toxicity?5 answersReceptor heterogeneity can be used to predict drug response or toxicity. Breast cancer cell lines exhibit high heterogeneity in the expression of clinically relevant biomarkers, enabling cells with differential drug sensitivity to co-exist in the same population. Single-cell response data can be utilized to identify regulatory reactions driving population heterogeneity in drug response, providing regulatory targets to curb the cell dynamics of drug resistance. Incorporating the heterogeneity of samples in model training and prediction improves the performance of drug sensitivity predictive models. Therefore, considering receptor heterogeneity can help in predicting drug response and designing effective treatment strategies.

How can receptor heterogeneity be exploited to develop new drugs?5 answersReceptor heterogeneity can be exploited to develop new drugs by targeting receptor heteromers, which are complexes formed by the interaction of multiple receptors. These heteromers have distinct pharmacological profiles and can be considered as new drug targets, allowing for greater specificity and selectivity in drug development. For example, the calcium-sensing receptor (CaSR) activates different G protein subfamilies, and understanding the specific G protein activation patterns can aid in the development of pharmacological compounds targeting CaSR. Dopamine receptors, which form heteromers, have the potential to modify the pharmacological features of individual receptors, providing opportunities for the development of selective drug candidates for dopamine-related disorders. Additionally, understanding the composition and function of antibody-binding Fcγ receptors (FcγRs) can lead to the development of improved FcγRs for therapeutic purposes. Overall, exploiting receptor heterogeneity can provide insights into novel drug targets and enhance drug development strategies.

Are there molecular strategies to inhibit the alpha 1 adrenergic receptor in a murine model?5 answersThere are molecular strategies to inhibit the alpha 1 adrenergic receptor in a murine model. One approach is the use of subtype-selective drugs, such as the alpha 1B -AR selective antagonist conopeptide p-TIA. Another strategy involves the molecular approach of transfecting constitutively active alpha-1 adrenergic receptors into cardiac cells to study the signaling pathways and downstream genes activated by specific subtypes. Additionally, a novel class of compounds with affinity for alpha(1) adrenergic receptors has been synthesized, showing high affinity for the receptor. These molecular strategies provide potential ways to inhibit the alpha 1 adrenergic receptor in a murine model.

See what other people are reading

How to separate fgf10 ligand from receptor in the fusion protein?

To separate the FGF10 ligand from the receptor in the fusion protein, a novel approach can be employed by utilizing multivalent ligands. By generating multivalent FGFR1 ligands, as described in, the ligand-receptor interaction can be modulated. These multivalent ligands trigger receptor clustering on the cell surface, enhancing the efficiency of receptor endocytosis and modifying receptor signaling, ultimately influencing cell fate. Additionally, fusion proteins with G protein alpha subunits and G-protein-coupled receptors have been used to explore ligand stimulation and information transfer mechanisms. Furthermore, the genetic fusion of monomeric protein domains to soluble TNF superfamily ligands has been shown to have no effect on ligand activity and receptor binding, allowing for the generation of bioluminescent fusion proteins for cellular binding studies.How does the RAS gene contribute to the development of preeclampsia?

The renin-angiotensin system (RAS) plays a crucial role in the pathogenesis of preeclampsia (PE). Dysregulation of the RAS gene components, such as angiotensin-converting enzyme (ACE) and angiotensin II (Ang II), contributes to the development of PE. Genetic variations in the ACE gene, like the rs4343 polymorphism, have been associated with an increased risk of PE. Additionally, the overactivation of the Ang II/ACE/AT1R axis, along with decreased levels of protective components like ACE 2/Ang 1–7/MasR, can lead to hypertension characteristic of PE. Furthermore, studies suggest that the compensatory alterations in the RAAS during normal pregnancy are disrupted in PE, leading to a disturbance in the delicate equilibrium necessary for maternal and fetal well-being. These findings highlight the intricate involvement of the RAS gene in the pathogenesis of preeclampsia.Cannabinoid receptor-G protein interactions: Gαi1-bound structures of IC3 and a mutant with altered G protein specificity

The interaction between the cannabinoid receptor one (CB1) and G proteins, specifically Gαi1, plays a crucial role in signal transduction. Structural studies have revealed that the C-terminal region of the third cytoplasmic loop (IC3) of CB1 must maintain a helical conformation for efficient coupling and activation of the Gi protein. Additionally, the second intracellular loop (ICL2) of CB1 has been identified as a key determinant in mediating selective coupling to both Gs and Gi proteins, with Leu-222 playing a critical role in this specificity. These findings highlight the structural elements within CB1 that govern its interactions with different G proteins, shedding light on the mechanisms underlying cannabinoid receptor-G protein selectivity.How does ace inhibitors affect plasma metanephrine?

ACE inhibitors can influence plasma metanephrine levels by affecting catecholamine release and sympathetic nerve activity. Studies have shown that ACE inhibitors like ramipril can lead to diminished release of noradrenaline, a type of catecholamine, from sympathetic nerves, indicating a potential inhibitory effect on noradrenaline release. Additionally, ACE inhibitors may indirectly impact the reuptake mechanism of noradrenaline, potentially altering its concentration in plasma. Furthermore, the use of sensitive assays has revealed a positive correlation between plasma metanephrines (normetanephrine and metanephrine) and catecholamines, suggesting a link between these compounds in the bloodstream. Overall, ACE inhibitors can modulate plasma metanephrine levels through their effects on sympathetic nerve activity and catecholamine release.Challenge: always a good thing?

Challenge is not always universally positive, as highlighted in the contexts. While challenge is often associated with growth, excitement, and resistance to authority, it can also lead to negative outcomes. For instance, in the educational setting, challenging material can trigger feelings of panic and low self-esteem, hindering learning progress for some students. Moreover, in healthcare, excessive screening practices like Pap smears can lead to overutilization, causing harm and displacing other important health concerns. Therefore, while challenges can stimulate ambition and improvement, it is crucial to recognize that they may not always be beneficial and can sometimes result in adverse consequences.What is the novelty of corn silk tea?

The novelty of corn silk tea lies in its diverse health benefits and bioactive components. Corn silk tea has been traditionally used for its anti-hypertensive properties, with studies identifying ACE inhibitory peptides like CSBp5 in corn silk. Additionally, corn silk black tea has diuretic, heat-reducing, and cholesterol-lowering effects. Furthermore, a health tea beverage made from corn silk, hemp seed, and honeysuckle flower offers various health benefits such as blood pressure and blood sugar reduction. The utilization of corn silk in creating Maize Silk Tea not only reduces environmental impact but also provides a nutritious beverage with high acceptance levels. Moreover, the preparation method for corn silk instant health-care tea combines corn silk, black tea, and coffee powder for a functional and low-sugar instant tea suitable for diabetic patients.Can the amino acid proline inhibit the activity of the angiotensin-converting enzyme? Why?

Proline can inhibit the activity of the angiotensin-converting enzyme (ACE) due to its role in the structure of ACE inhibitory peptides. Research has shown that peptides containing a C-terminal proline exhibit ACE inhibitory activity. Proline-containing peptides like Leucine-Lysine-Proline (LKP) and Isoleucine-Proline-Proline (IPP) have been identified as ACE inhibitors. The presence of proline in these peptides enhances their stability and interaction with ACE through various bonding interactions, such as hydrogen bonds and Pi interactions. Additionally, the addition of exogenous proline to sea cucumber hydrolysates led to the production of efficient ACE-inhibitory peptides, demonstrating the importance of proline in enhancing ACE inhibition. Proline's unique structural characteristics contribute to the inhibitory activity of ACE inhibitory peptides.Can the use of sartans increase the likelihood of experiencing a cough?

The use of sartans, specifically angiotensin receptor blockers (ARBs), is associated with a lower likelihood of experiencing a cough compared to angiotensin-converting enzyme inhibitors (ACEIs). ACEIs are known to cause a persistent dry cough in many patients, attributed to increased concentrations of bradykinin. In contrast, ARBs like telmisartan have shown significantly lower incidences of cough compared to ACEIs like lisinopril. Studies have indicated that ARBs are superior to ACEIs in preventing cardiac mortality and morbidity, with ACEIs having a higher risk of inducing cough. Therefore, if a patient is prone to developing a cough, especially with ACEIs, switching to ARBs may be a suitable alternative to mitigate this side effect.What is the role of lemon extract in local studies?

Local studies have highlighted various beneficial roles of lemon extract. Lemon peel extracts have shown antioxidant, antimicrobial, and antiproliferative properties, enhancing Labneh quality and improving sensory properties of the product. Lemon extract has been linked to improved insulin sensitivity and lipid breakdown in adipocytes, potentially aiding in weight loss and reducing cardiovascular risks. Moreover, lemon extract has demonstrated cognitive benefits in Alzheimer's disease models, enhancing learning and memory abilities through synaptic strengthening and protection against neural lesions. Additionally, lemon peel extracts have exhibited antimicrobial effects against various pathogens, making them effective microbicidal agents with antioxidant properties, suggesting their potential as natural therapeutic agents. Furthermore, waste lemon extract has shown promise in soil remediation, effectively removing toxic metals while preventing soil acidification, thus promoting plant growth.What are the underlying mechanisms linking cerebral infarction and hypertension?

Cerebral infarction and hypertension are linked through various mechanisms. Hypertension leads to structural vascular changes, increasing peripheral resistance and reducing collateral capacity, predisposing to ischemia and infarcts. Angiotensin II (AngII) and its type-1 receptors play a role in hypertension and ischemic stroke, affecting blood-brain barrier function and blood cell adhesion in cerebral microvasculature. Gene polymorphisms, like the ACE gene, are associated with cerebral infarction in hypertensive patients, potentially increasing the risk of incidence. Additionally, cerebral artery hypoperfusion may trigger hypertension through inflammatory-driven artery remodeling, leading to increased stiffness and resistance, which could contribute to stroke development. These findings collectively highlight the intricate relationship between cerebral infarction and hypertension, involving vascular changes, genetic factors, and inflammatory responses.What effect does PTZ have on serotonin receptors?

PTZ, or pentylenetetrazole, induces changes in serotonin (5-HT) receptors. Studies have shown that PTZ administration leads to alterations in serotonin levels in various brain regions. Specifically, PTZ-induced epilepsy results in a significant decrease in serotonin levels in different brain regions. Furthermore, the interaction between serotonin receptors and other neurotransmitters like dopamine and noradrenaline is modulated during the postictal stage, affecting motor deficits. These findings suggest that PTZ impacts serotonin receptors by influencing their levels and interactions with other neurotransmitters, highlighting the complex role of serotonin in the context of seizures and related neurological processes.